Health-care companies ticked down as traders hedged their bets on the outlook for growth in the sector.

Novo Nordisk declined even after the Food and Drug Administration said there was no evidence the Glucagon-like Peptide-1 receptor agonist weight-loss drugs, such as Novo's Ozempic, cause suicidal ideation.

CVS Health plans to close dozens of pharmacies inside Target stores at a time when pharmacy chains are struggling to grow retail profits.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

01-11-24 1808ET